

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, sevasemten, an orally administered small molecule that is in Phas...
Q2 2026
Aug 6, 2026
Q1 2026
May 7, 2026
FY 2025
Feb 26, 2026
Q4 2025
Feb 26, 2026
Q3 2025
Nov 6, 2025